Innovative Immunotherapy in Advanced Basal Cell Carcinoma

Chair and Moderator, Karl D. Lewis, MD, Ragini R. Kudchadkar, MD, and Michael R. Migden, MD, discuss basal cell carcinoma in this CME/MOC/NCPD/CPE activity titled “Innovative Immunotherapy in Advanced Basal Cell Carcinoma: Evolving Science, Key Clinical Evidence, and Implications for Multidisciplinary Management.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/TPR865. CME/MOC/NCPD/CPE credit will be available until June 24, 2022.